Show simple item record

Protocol for the MelaTools Skin Self-Monitoring Trial : a phase II randomised controlled trial of an intervention for primary care patients at higher risk of melanoma

dc.contributor.authorMills, K
dc.contributor.authorEmery, JD
dc.contributor.authorLantaff, R
dc.contributor.authorRadford, M
dc.contributor.authorPannebakker, MM
dc.contributor.authorHall, P
dc.contributor.authorBurrows, NP
dc.contributor.authorWilliams, KM
dc.contributor.authorSaunders, CL
dc.contributor.authorMurchie, Peter
dc.contributor.authorWalter, Fiona M
dc.date.accessioned2017-12-06T17:43:14Z
dc.date.available2017-12-06T17:43:14Z
dc.date.issued2017-11
dc.identifier.citationMills , K , Emery , JD , Lantaff , R , Radford , M , Pannebakker , MM , Hall , P , Burrows , NP , Williams , KM , Saunders , CL , Murchie , P & Walter , F M 2017 , ' Protocol for the MelaTools Skin Self-Monitoring Trial : a phase II randomised controlled trial of an intervention for primary care patients at higher risk of melanoma ' , BMJ Open , vol. 7 , 017934 . https://doi.org/10.1136/bmjopen-2017-017934en
dc.identifier.issn2044-6055
dc.identifier.otherPURE: 107822327
dc.identifier.otherPURE UUID: 4d290e21-1ffd-46af-9faf-22976b9d53af
dc.identifier.otherScopus: 85045986999
dc.identifier.urihttp://hdl.handle.net/2164/9690
dc.descriptionThis work was supported by FMW’s Clinician Scientist award (RG 68235) from the National Institute for Health Research (NIHR). The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health. The funding source has no role in the design of this study, the interpretation of data, or the decision to submit results. The paper also presents independent research funded/supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research & Care (CLAHRC) East of England, at Cambridgeshire and Peterborough NHS Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health,en
dc.language.isoeng
dc.relation.ispartofBMJ Openen
dc.rightsThis is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/en
dc.subjectmelanomaen
dc.subjectskin canceren
dc.subjectrandomised controlled trialen
dc.subjectrisk-stratifieden
dc.subjectprimary careen
dc.subjectR Medicineen
dc.subjectNational Institute for Health Research (NIHR)en
dc.subject.lccRen
dc.titleProtocol for the MelaTools Skin Self-Monitoring Trial : a phase II randomised controlled trial of an intervention for primary care patients at higher risk of melanomaen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Data Safe Havenen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1136/bmjopen-2017-017934


Files in this item

Thumbnail
Name:
Protocol_for_the_melatools_ski ...
Size:
916.8Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record